Renier Myburgh

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosis.

CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosis.

Journal: Leukemia
Published: July 23, 2025

Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells.

Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells.

Journal: Leukemia
Published: June 03, 2024

A single-chain variable fragment-based bispecific T-cell activating antibody against CD117 enables T-cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cells.

A single-chain variable fragment-based bispecific T-cell activating antibody against CD117 enables T-cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cells.

Journal: HemaSphere
Published: March 26, 2024

Erratum: Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells.

Erratum: Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells.

Journal: Molecular therapy oncolytics
Published: September 01, 2023

Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.

Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.

Journal: Neuro-oncology
Published: June 19, 2023

Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells.

Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells.

Journal: EMBO molecular medicine
Published: March 27, 2023

Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells.

Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells.

Journal: Molecular therapy oncolytics
Published: January 13, 2023

Publisher Correction: Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications.

Publisher Correction: Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications.

Journal: Nature chemistry
Published: June 09, 2021

Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells.

Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells.

Journal: Experimental hematology
Published: November 23, 2020

Disruption of CSF-1R signaling inhibits growth of AML with inv(16).

Disruption of CSF-1R signaling inhibits growth of AML with inv(16).

Journal: Blood advances
Published: August 05, 2020

Impact of Ligand Size and Conjugation Chemistry on the Performance of Universal Chimeric Antigen Receptor T-Cells for Tumor Killing.

Impact of Ligand Size and Conjugation Chemistry on the Performance of Universal Chimeric Antigen Receptor T-Cells for Tumor Killing.

Journal: Bioconjugate chemistry
Published: June 10, 2020

Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia.

Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia.

Journal: Nature communications
Published: May 27, 2020
Showing 1-12 of 27

Last Updated: 09/26/2026